Not applicableStudy completedNCT07662265What this trial is testingTocilizumab in Refractory ASS-ILDWho this might be right forAntisynthetase SyndromeTocilizumab Hu Yinan 111
Not applicableLooking for participantsNCT07374107What this trial is testingMIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)Who this might be right forIBMIIMMyositis+9 more Myositis International Health & Research Collaborative Alliance Foundation 700
Testing effectiveness (Phase 2)Ended earlyNCT05650567What this trial is testingStudy of M5049 in DM and PM Participants (NEPTUNIA)Who this might be right forDermatomyositisPolymyositis EMD Serono Research & Development Institute, Inc. 20
Not applicableUnknownNCT04941547What this trial is testingAssociation Between Cancer and Anti-synthetase SyndromeWho this might be right forAntisynthetase Syndrome Central Hospital, Nancy, France 200
Large-scale testing (Phase 3)Looking for participantsNCT06154252What this trial is testingRESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory MyopathyWho this might be right forIdiopathic Inflammatory MyopathyDermatomyositisAnti-Synthetase Syndrome+5 more Cabaletta Bio 74
Early research (Phase 1)Looking for participantsNCT07085104What this trial is testingInvestigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune DiseaseWho this might be right forSystemic Lupus Erythematosus (With and Without Nephritis)Idiopathic Inflammatory MyopathySystemic Sclerosis Allogene Therapeutics 66
Testing effectiveness (Phase 2)Study completedNCT00774462What this trial is testingRituximab for the Treatment of Refractory Inflammatory Myopathies and Refractory Myasthenia GravisWho this might be right forMyositisMyasthenia Gravis Assistance Publique - Hôpitaux de Paris 30
Testing effectiveness (Phase 2)Study completedNCT03215927What this trial is testingAbatacept for the Treatment of Myositis-associated Interstitial Lung DiseaseWho this might be right forMyositisInterstitial Lung Disease Rohit Aggarwal, MD 20
Not applicableLooking for participantsNCT01276470What this trial is testingEnvironmental Risk Factors for the Anti-synthetase SyndromeWho this might be right forMyositisDermatomyositisPolymyositis+2 more National Institute of Environmental Health Sciences (NIEHS) 580
Early research (Phase 1)Active Not RecruitingNCT06255028What this trial is testingCNTY-101 in Participants With Refractory B Cell-mediated Autoimmune DiseasesWho this might be right forSystemic Lupus ErythematosusLupus NephritisIdiopathic Inflammatory Myopathies+1 more Century Therapeutics, Inc. 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT06665256What this trial is testingPhase 2 Study of Rapcabtagene Autoleucel in MyositisWho this might be right forIdiopathic Inflammatory Myopathies Novartis Pharmaceuticals 21
Not applicableNot Yet RecruitingNCT07836790What this trial is testingA Randomized, Double-Blind, Placebo-Controlled Trial of Fufei Huazhuo Tongluo Formula Combined With Standardized Medicine in Patients With Anti-Synthetase Syndrome-Associated Interstitial Lung DiseaseWho this might be right forAnti-Synthetase SyndromeInterstitial Lung Disease (ILD) First People's Hospital of Hangzhou 54
Testing effectiveness (Phase 2)Study completedNCT05669014What this trial is testingProof of Concept Study to Evaluate the Efficacy and Safety of Daxdilimab in Participants With Dermatomyositis (DM) or Anti-synthetase Inflammatory Myositis (ASIM)Who this might be right forIdiopathic Inflammatory Myositis Amgen 12